Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Service income	19.08M	9.63M	15.46M	18.86M	24.72M
Pharmaceutical Distribution	152.16M	103.92M	119.58M	93.00M	134.70M
Unallocated Other Operating Income	13.73M	13.06M	21.34M	19.13M	14.61M
Pharmaceutical Manufacturing	590.72M	668.99M	739.21M	753.60M	1.05B
Total	775.69M	795.60M	895.59M	884.59M	1.23B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	775.69M	795.60M	895.59M	884.59M	1.23B
Total	775.69M	795.60M	895.59M	884.59M	1.23B

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error